IB
TEVA icon

Intrust Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Intrust Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,220
Closed -$382K – 284
2014
Q1 		$382K Sell
7,220
-140
-2% -$6.47K 0.16% 183
2013
Q4 		$295K Sell
7,360
-1,474
-17% -$58K 0.13% 210
2013
Q3 		$334K Sell
8,834
-10,580
-54% -$413K 0.16% 183
2013
Q2 		$761K Buy
+19,414
New +$756K 0.34% 99

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Intrust Bank's TEVA Position: Q2 2014 in Review

Intrust Bank sold out of Teva Pharmaceuticals (TEVA) in Q2 2014, closing a stake of 7,220 shares — an estimated $382K sold.

Intrust Bank first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $761K in Q2 2013. 779 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

  • Intrust Bank reported no remaining Teva Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Intrust Bank sold 7,220 Teva Pharmaceuticals shares in Q2 2014, an estimated $382K.
  • Intrust Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Intrust Bank's Teva Pharmaceuticals position peaked at $761K in Q2 2013.
  • 779 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2014.

Based on Intrust Bank's 13F filing for Q2 2014, filed 14 Aug 2014.